Stay updated with breaking news from High Acuity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com started coverage on shares of Amedisys (NASDAQ:AMED – Get Rating) in a report published on Wednesday morning. The firm issued a buy rating on the health services provider’s stock. AMED has been the topic of several other reports. Benchmark reiterated a buy rating and set a $115.00 target price on shares of Amedisys in […]
Schroder Investment Management Group reduced its position in shares of Amedisys, Inc. (NASDAQ:AMED – Get Rating) by 12.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 471,160 shares of the health services provider’s stock after selling 67,464 shares during […]
StockNews.com assumed coverage on shares of Amedisys (NASDAQ:AMED – Get Rating) in a report published on Tuesday. The firm issued a buy rating on the health services provider’s stock. Several other equities analysts have also recently weighed in on AMED. Barclays cut their price objective on Amedisys from $93.00 to $88.00 in a research report […]
StockNews.com assumed coverage on shares of Amedisys (NASDAQ:AMED – Get Rating) in a research note issued to investors on Tuesday. The brokerage issued a buy rating on the health services provider’s stock. Other analysts have also issued research reports about the company. Stephens reaffirmed an equal weight rating and set a $103.00 price objective on […]
Nicholas Company Inc. increased its stake in shares of Amedisys, Inc. (NASDAQ:AMED – Get Rating) by 14.2% during the 4th quarter, Holdings Channel reports. The institutional investor owned 60,242 shares of the health services provider’s stock after buying an additional 7,485 shares during the period. Nicholas Company Inc.’s holdings in Amedisys were worth $5,033,000 at […]